Fenbendazole and Ivermectin for Turbo Cancer: ChatGPT vs Grok 2 (2025)

By Editorial Team -

In the rapidly evolving field of artificial intelligence, two chatbots have captured significant attention: Elon Musk’s Grok 2 and OpenAI’s ChatGPT. Both excel at natural language processing, yet Grok 2 offers distinctive features that set it apart. 

Since experts are so often wrong, we figured it wouldn't be a bad idea to put AI to work and ask ChatGPT and Grok 2.


We queried ChatGPT and Grok 2 on "Fenbendazole and Ivermectin for Turbo Cancer", and the following is what we found.

Can the fenbendazole and ivermectin combination treat turbo cancer?

ChatGPT: Can the fenbendazole and ivermectin combination treat turbo cancer?

The combination of fenbendazole (a veterinary antiparasitic medication) and ivermectin (another antiparasitic drug) is not recognized or approved as a treatment for cancer, including so-called "turbo cancer." The term "turbo cancer" is not a medical term and is typically used informally to describe cancers that grow or spread rapidly.

Current Evidence:

  1. Fenbendazole:

    • Some studies have investigated fenbendazole for potential anticancer properties, primarily in laboratory settings (e.g., on cell lines or animal models). Fenbendazole appears to disrupt cellular microtubules, similar to certain chemotherapy drugs like taxanes. However, there is no high-quality clinical evidence to suggest that it is effective or safe for treating human cancers.

  2. Ivermectin:

    • Ivermectin has shown some potential anticancer effects in laboratory studies, including inducing apoptosis (cell death) and inhibiting tumor growth in some cancer models. However, these findings are preliminary, and ivermectin is not approved as a cancer treatment in humans.

  3. Combination Therapy:

    • There is no validated clinical research to support the safety or efficacy of using fenbendazole and ivermectin together for treating cancer. Combining drugs without evidence can pose risks of toxicity or harmful side effects.

Risks and Concerns:

  • Lack of Clinical Trials: Neither fenbendazole nor ivermectin has undergone rigorous clinical trials to establish them as cancer treatments.
  • Unregulated Use: Using veterinary medications off-label for humans is risky due to differences in dosing, formulation, and quality control.
  • Potential Harm: Unproven treatments can delay access to effective, evidence-based therapies, potentially worsening outcomes.

Evidence-Based Cancer Treatments:

If you or someone you know is dealing with cancer, it is crucial to consult with an oncologist. Cancer treatment often involves a combination of surgery, chemotherapy, radiation, immunotherapy, or targeted therapies based on the type and stage of cancer.

If you are interested in alternative or experimental therapies, it is best to discuss them with your healthcare provider to ensure safety and proper integration with conventional treatments.


Grok 2: Can the fenbendazole and ivermectin combination treat turbo cancer?


12 posts
25 web pages
The combination of fenbendazole and ivermectin has been discussed in various contexts as a potential treatment for cancers, including what some refer to as "turbo cancer," a term sometimes used to describe rapidly progressing cancers potentially linked to certain conditions or treatments like mRNA vaccines. Here's an overview based on available information:

  • Preclinical Studies and Anecdotal Evidence: There are studies and anecdotal reports suggesting that both fenbendazole and ivermectin might have antitumor properties. Fenbendazole, primarily used as an antiparasitic in veterinary medicine, has shown in preclinical studies (animal and cell culture) to have effects on various cancer types by mechanisms like inhibiting microtubule function, which can lead to cancer cell death. Similarly, ivermectin has been investigated for its potential to induce apoptosis (programmed cell death) in cancer cells, inhibit cancer stem cells, and reverse drug resistance. Some posts on X and web articles mention cases where individuals reportedly improved after using these drugs in combination, particularly in contexts of aggressive or treatment-resistant cancers.
  • Lack of Human Clinical Trials: While these drugs show promise in preclinical research, there is a significant gap in human clinical trial data specifically for cancer treatment, especially regarding "turbo cancer." Most of the research cited involves animal models or in vitro studies, which do not directly translate to human efficacy or safety. The absence of large-scale, randomized controlled trials in humans means that their effectiveness and safety for this specific application are not well-established.
  • Safety and Dosage Concerns: Fenbendazole is not approved for human use by the FDA for cancer treatment, and while ivermectin is used in humans for parasitic infections, its use in cancer treatment at potentially higher doses could carry risks not thoroughly explored. Combining these drugs could lead to unforeseen interactions or side effects.
  • Current Medical Perspective: The medical community often views such off-label uses with caution due to the lack of rigorous scientific validation. The American Cancer Society and similar organizations stress the importance of conventional treatments alongside any complementary or alternative therapies, with the latter only under medical supervision due to the potential for harm or interference with standard cancer treatments.
  • Conclusion: While there is some enthusiasm around the potential of fenbendazole and ivermectin in combination for treating cancers, including aggressive forms, the evidence is currently limited to preclinical data and anecdotal reports. For any cancer treatment, especially one as aggressive as "turbo cancer," patients should consult with oncologists or integrative medicine specialists who can provide guidance based on current scientific understanding and individual health profiles.

Given the complexity and the evolving nature of cancer research, individuals interested in these treatments should approach them with caution, seek thorough medical advice, and remain open to conventional treatments which have more established efficacy and safety profiles.


What dose of Ivermectin and Fenbendazole to treat Turbo Cancer?

ChatGPT: What dose of Ivermectin and Fenbendazole to treat Turbo Cancer?

There is currently no evidence-based treatment protocol involving ivermectin for managing cancer, including speculative claims about "mRNA vaccine turbo cancer." The concept of "turbo cancer" as a direct consequence of mRNA COVID-19 vaccines lacks scientific validation, and ivermectin has not been proven to treat cancer or any vaccine-related conditions.

Key Points:

  1. No Established Link Between COVID-19 Vaccines and "Turbo Cancer":

    • COVID-19 vaccines, including mRNA vaccines (Pfizer-BioNTech and Moderna), have undergone extensive clinical trials and post-marketing surveillance.
    • Studies show no credible evidence linking mRNA vaccines to an increased risk of cancer or a phenomenon such as "turbo cancer."

  2. Ivermectin and Cancer:

    • While preclinical studies suggest ivermectin has anticancer potential, no clinical trials have validated its safety or efficacy in treating cancer in humans.
    • There are no guidelines for ivermectin dosing for cancer treatment, and high doses pose serious risks, including neurotoxicity.

  3. COVID-19 Vaccines and Safety:

    • The vast majority of side effects from COVID-19 vaccines are mild and short-lived (e.g., soreness, fatigue, fever).
    • Severe adverse events are rare and extensively monitored by organizations like the CDC and WHO.

What Should You Do?

If you or someone you know is dealing with a cancer diagnosis:

  1. Consult an Oncologist:
    • Seek professional medical advice to explore proven treatment options tailored to the specific cancer type.
  2. Avoid Unproven Treatments:
    • Using unverified therapies like ivermectin could delay effective treatment and potentially worsen outcomes.
  3. Report Concerns to a Healthcare Professional:
    • If you suspect a health issue related to a COVID-19 vaccine, report it to health authorities (e.g., VAERS in the U.S.) and consult your doctor.

Conclusion

There is no scientific basis for using ivermectin to treat cancer, including unverified claims of "mRNA vaccine turbo cancer." Treatment decisions should be based on evidence and guided by qualified healthcare professionals. For cancer concerns, stick to proven therapies and clinical trials. If you have concerns about vaccines, consult credible sources like the CDC, WHO, or a trusted healthcare provider.


Grok 2: What dose of Ivermectin and Fenbendazole to treat Turbo Cancer?


14 posts
25 web pages
Determining the exact dosage of ivermectin and fenbendazole for treating "turbo cancer" is challenging due to the lack of standardized, scientifically-backed protocols for this specific use. Here's what can be inferred from available sources:

  • Ivermectin:
    • Some posts on X mention dosages like:
      • 12mg ivermectin 4 times in a 2-week period for skin cancer spots ().
      • 18 mg for a case of stage 4 turbo cancer ().
      • High-dose protocols for various cancers, suggesting 5 to 10 times the COVID-19 treatment dose, which could mean around 24mg or higher daily ().
    • However, these are anecdotal and not from controlled medical studies. For cancer treatment, some sources suggest:
      • 1 mg/kg/day in severe cases (,).
  • Fenbendazole:
    • Dosages mentioned in testimonials include:
      • 444mg daily for a few days ().
      • 300 mg, 6 days a week, or up to 1 gram for severe cases ().
    • A study suggested a regimen of 1 gram daily for 3 days, followed by 4 days off ().

It's crucial to emphasize:

  • Safety and Efficacy: These drugs are not approved by regulatory bodies like the FDA for cancer treatment. Their use in humans for this purpose is largely based on anecdotal evidence or very preliminary research.
  • Medical Supervision: Any use of these medications, especially at these doses for cancer treatment, should be under strict medical supervision. Side effects, drug interactions, and the lack of long-term safety data are significant concerns.
  • Individual Variability: Dosages might need to be adjusted based on individual health status, other medications, and the specific cancer type or stage.
  • Lack of Clinical Trials: There are no conclusive human clinical trials supporting these dosages for cancer therapy, particularly for "turbo cancer," which is not a medically recognized term but rather a colloquial one for rapidly progressing cancers.

Given these points, if you or someone you know is considering these treatments:

  • Consult Healthcare Providers: Discuss with oncologists or integrative medicine specialists. They can provide guidance based on current medical knowledge and your specific health situation.
  • Monitor for Side Effects: Use of these medications off-label for cancer treatment should be done with caution, monitoring for any adverse effects.
  • Complementary, Not Alternative: These should not replace conventional cancer treatments unless advised by a healthcare professional.

Remember, the information provided here is based on limited data and should not be taken as definitive medical advice.

Discussion

Based on the above answers, Grok 2 has a distinctive advantage. Grok 2 taps directly into X and the web, making it a strong choice for real-time events.

The anecdotal nature of various reports precludes definitive conclusions about the efficacy of fenbendazole and ivermectin as a turbo cancer treatment. However, the consistency of positive outcomes across diverse cancer types suggests a potential biological effect that merits further investigation. 

The pattern of case reports also suggests that fenbendazole and ivermectin may exhibit broad-spectrum anticancer properties.

Comparatively, other repurposed anthelmintic drugs, such as mebendazole, have progressed further along the clinical research pipeline, with some reaching early-phase human trials. 

Future Directions

To address these challenges and advance the understanding of fenbendazole and ivermectin’s role in oncology, the following steps are recommended:

  • Controlled Clinical Trials: Randomized, double-blind studies are essential to establish fenbendazole and ivermectin’s efficacy and safety in humans.
  • Mechanistic Studies: Further research into fenbendazole and ivermectin’s molecular targets and pathways will clarify its anticancer properties and identify potential biomarkers of response.
  • Combination Therapy Research: Studies exploring fenbendazole and ivermectin in combination with standard treatments, such as chemotherapy and immunotherapy, may uncover synergistic effects.

Conclusion

As recommended by both ChatGPT and Grok 2, healthcare providers must guide its use with caution, and patients should not substitute it for evidence-based treatments. Collaborative efforts between researchers, clinicians, and regulatory bodies are essential to unlock fenbendazole and ivermectin’s full therapeutic potential while safeguarding patient safety.


Related:

Comments

Post a Comment

Labels

Show more

Archive

Show more

Popular posts from this blog

Ivermectin and Fenbendazole: Treating Turbo Cancer - Dr William Makis

By Editorial Team -
Image
Ivermectin Resources Recently, I have seen tremendous demand for some sort of initial guidance “WHERE TO START” with High Dose Ivermectin for CANCER. I have two articles and a Video that go into depth: June 10, 2024 - "15 minutes with Dr.Makis" - Episode 018: High Dose IVERMECTIN and CANCER 2024 - NEW STUDIES 2024 Baghli et al - Targeting the Mitochondrial-Stem Cell Connection in Cancer Treatment: A Hybrid Orthomolecular Protocol First-in-the-World Ivermectin, Mebendazole and Fenbendazole Protocol in Cancer has been peer-reviewed and published on Sep.19, 2024. Co-authors include Dr Paul Marik and Dr William Makis. 2024 Fan et al  - Ivermectin Inhibits Bladder Cancer Cell Growth and Induces Oxidative Stress and DNA Damage ( 2024 Man-Yuan Li et al ) - Ivermectin induces non-protective autophagy by downregulating PAK1 and apoptosis in lung adenocarcinoma cells ( 2024 Kaur et al ) - Ivermectin: A Multifaceted drug with a potential beyond anti-parasitic therapy ( 2024 Xing Hu et ...
Read more

Fenbendazole Joe Tippens Protocol: A Step-by-Step Guide (2025)

By Editorial Team -
Image
If you have been diagnosed with cancer, or have a loved one that is suffering from cancer, chances are you have heard about the Joe Tippens Cancer Protocol. The Fenbendazole Cancer Protocol has been gaining rapid interest over the past years following some fenbendazole advanced cancer success stories . We have seen tremendous demand for some sort of guide on how to use fenbendazole for cancer as there is also tremendous confusion both from the healthcare and non-healthcare communities. Joe Tippens founded the protocol (1) after he was told a story about a scientist at Merck Animal Health that had been performing cancer research on mice. The research included injecting different types of cancers into different mice body parts. The scientists discovered, through trial and error, a product in their canine product line, fenbendazole, that was batting 1.000 in killing these different cancers in the mice. The scientist was later diagnosed with ...
Read more

Ivermectin, Fenbendazole and Mebendazole in Cancer: 2024 Peer-Reviewed Protocol in Cancer

By Editorial Team -
Image
We are pleased to announce that the first-of-its-kind protocol utilizing Ivermectin, Mebendazole, and Fenbendazole for cancer treatment has been peer-reviewed and officially published on September 19, 2024. Spearheaded by leading researchers like Dr. Ilyes Baghli, Dr. Pierrick Martinez, and the FLCCC’s Dr. Paul Marik, this groundbreaking protocol harnesses the untapped power of Ivermectin, Mebendazole, and Fenbendazole, known for their effectiveness against parasites. Now, these drugs are showing potential to battle cancer, marking the dawn of a new treatment evolution. This trio of repurposed drugs has been shown to disrupt the growth of cancer cells, particularly by targeting microtubules, the essential structures that allow cancer to multiply uncontrollably. What makes this protocol even more potent is the synergistic effect when these drugs are used together, creating a powerful new affordable weapon against cancer. According to oncologist Dr William Makis: “ This paper is the FIR...
Read more

Fenbendazole Cancer Success Stories: 119 Case Reports Compilation (March 2025 Edition)

By Editorial Team -
Image
Contents: Editor's Preface Introduction Fenbendazole Case Series Compilation (alphabetical) Appendix Cancer Breast Cancer Success Stories (11 cases) Brain Cancer (Glioblastoma) Bile Duct Cancer (Cholangiocarcinoma) Bladder Cancer Success Stories (5 cases) Cervical Cancer Colorectal Cancer (11 cases) Esophageal and Stomach cancer Endometrial Cancer (4 cases) Gastric (Stomach) cancer (3 cases) Head and Neck Cancer (3 cases) Kidney Cancer Case Series (8 cases) Liver Cancer (2 cases) Lung Cancer (11 cases) Leukemia (2 cases) Lymphoma (4 cases) Melanoma (Skin Cancer) Multiple Myeloma Myelodysplastic Syndrome Oral Cancer Ovarian Cancer (2 cases) Pancreatic Cancer (9 cases) Prostate Cancer (15 cases) Salivary Gland Cancer Sarcoma (2 cases) Skin ...
Read more

Fenbendazole: Questions Answered, Things to Know, Useful Tips - Ben Fen

By Editorial Team -
Image
Readers ask a variety of questions regarding the use of fenbendazole. This article is mainly a result of those questions and has been in the hopper for quite a while. It is long overdue as it contains items of importance that, if we waited for the appropriate thematic venue to publish them, they might never see the light of day. With that in mind, please accept the following for what it is: a hodgepodge of fenbendazole-related items that are very important to know. Incorporate these bits and pieces into your arsenal of ideas regarding fenbendazole, any unique insights that come to mind please feel free to share. How Safe is Fenbendazole? Is fenbendazole harmful to humans? Due to the long and successful use of fenbendazole as a veterinary antiparasitic medicine since the late 1950s, a wealth of safety data has been acquired that has stood the test of time. According to Drugs.com, there are no commonly used drugs that interact with fenbendazole.   Fenbendazole is so safe for veterina...
Read more

Fenbendazole vs Mebendazole for Cancer: What is the Difference?

By Editorial Team -
Image
What is fenbendazole used for in humans?  Fenbendazole (also known as fenben) is a veterinary medication used to treat parasites and worms such as tapeworms, hookworms, roundworms, and whipworms, in animals. It is commonly used under brand names like Panacur C and Safe-Guard. If you have been diagnosed with cancer, or have a loved one that is suffering from cancer, chances are you have heard about the Joe Tippens Cancer Protocol. The Fenbendazole Cancer Protocol has been gaining rapid interest over the past years following some fenbendazole advanced cancer success stories. Joe Tippens founded the protocol after he was told a story about a scientist at Merck Animal Health that had been performing cancer research on mice. The research included injecting different types of cancers into different mice body parts. The scientists discovered, through trial and error, a product in their canine product line, fenbendazole, that was batting 1.000 in killing these different cancers in the mic...
Read more

FENBENDAZOLE and CANCER: 15 Minutes with Dr. William Makis

By Editorial Team -
Image
Transcription (emphasis 2SG - 2nd Smartest Guy):  Hi, everyone. Welcome to another episode of 15 minutes with Dr. Makis, my new hard hitting medical podcast. This episode is about  fenbendazole  and cancer.  I will give you the most comprehensive review of the use of  fenbendazole  in cancer there is.   Fenbendazole  is an antiparasitic.  It is a dog dewormer, has been used It's been used as an antiparasitic since the 1960s,   and it has been shown to have extensive anti cancer activity.    Now, it's not FDA approved for use in humans. There is a version of it that is almost identical that is approved for use in humans by the FDA, and it's called mebendazole. (2SG: Mebendazole is BigPharma’s money grab whereby they removed a molecule from fenbendazole such that they could egregiously up-charge for a slightly inferior compound based on a bogus patent). I will do a separate video for mebe...
Read more

Fenbendazole: Side Effects, Safety and Dosage in Humans (2025)

By Editorial Team -
Image
Fenbendazole is a broad spectrum anthelmintic used against gastrointestinal parasites including: giardia, roundworms, hookworms, whipworms, the tapeworm genus Taenia (but not effective against Dipylidium caninum, a common dog tapeworm), pinworms, aelurostrongylus, paragonimiasis, strongyles, and strongyloides that can be administered to sheep, cattle, horses, fish, dogs, cats, rabbits, most reptiles, freshwater shrimp tanks as planaria and hydra treatments, as well as seals. One such study found unexpected tumor growth inhibition in a group of mice treated with a combination of Fenbendazole and vitamins. As more studies emerge – some already published, some currently ongoing – a rapidly growing number of human patients are taking Fenbendazole to treat their cancer. The Fenbendazole Cancer Protocol has been gaining rapid interest over the past years following some fenbendazole advanced cancer success stories. Joe Tippens founded the protocol  after he was told a story about a s...
Read more

Kidney and Gastro Issues Linked to Ozempic (Semaglutide)

By Editorial Team -
Image
The latest weight loss craze to hit Hollywood and beyond is semaglutide, more popularly known as Ozempic, the brand name of the drug marketed to improve blood sugar in people with Type 2 diabetes. Semaglutide is also known as Wegovy, which is prescribed to adults interested in weight loss. The weekly injectable drug is available only by prescription — and costs $1,349 a month (1) — but it’s in high demand among those looking to shed a few pounds. Note: Semaglutide is known by the brand names Ozempic, Wegovy, Rybelsus and others. New York dermatologist Dr. Paul Jarrod Frank told People, "It's the drug of choice these days for the 1%."(2) He says he can always spot users due to "Ozempic face," a gaunt appearance that can occur due to fat loss, which may make you appear older, particularly in the face. But this undesirable side effect is the least of your worries if you choose to use semaglutide. The blockbuster drug, slated to bring in more than $10 billion in ann...
Read more

Best Ivermectin Dosage for Humans with Cancer or Different Cancer Types (2024)

By Editorial Team -
Image
Introduction This article discusses dosage considerations and key factors regarding the use of ivermectin in cancer treatment. Commonly available information about ivermectin dosages is often inaccurate when applied to potential cancer-related uses.  Many sources cite standard dosages recommended by Merck for treating parasitic infections, rather than dosages studied specifically in the context of cancer research. The anti-parasitic dosage is not as effective for people looking for a dosage against cancer. Dosage will need to be adjusted according to cancer type and stage. Ivermectin dosage should be based on ivermectin cancer studies. Multiple factors are considered including studies including ivermectin for cancer, anecdotal studies and case series, the aggressiveness of the cancer type and the cancer stage. Cancer dosage estimation can be adjusted based on the time that a person has to beat cancer or its risk to the patient - this includes both the cancer type and whether the ca...
Read more